Article History
Received: 14 April 2021
Accepted: 18 November 2021
First Online: 6 December 2021
Declarations
:
: The use of the Optum claims databases was reviewed by the New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subjects research. All data were de-identified and HIPAA compliant, and all methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: DMK is an employee of Janssen Research & Development and owns stock in Johnson & Johnson. MSC and FW were employees of Janssen Research & Development when this study was conducted.